NPTH Stock Overview
Provides chronic pain management services in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NeuPath Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.21 |
| 52 Week High | CA$0.24 |
| 52 Week Low | CA$0.14 |
| Beta | 0.63 |
| 1 Month Change | 5.00% |
| 3 Month Change | 27.27% |
| 1 Year Change | 20.00% |
| 3 Year Change | -53.33% |
| 5 Year Change | n/a |
| Change since IPO | -76.67% |
Recent News & Updates
NeuPath Health Inc. (CVE:NPTH) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Jan 01
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel
Aug 18These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively
Jun 16Recent updates
NeuPath Health Inc. (CVE:NPTH) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Jan 01Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel
Aug 18These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively
Jun 16The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues
Aug 19Shareholder Returns
| NPTH | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -1.8% |
| 1Y | 20.0% | 28.1% | 16.1% |
Return vs Industry: NPTH underperformed the Canadian Healthcare industry which returned 28.1% over the past year.
Return vs Market: NPTH exceeded the Canadian Market which returned 16.1% over the past year.
Price Volatility
| NPTH volatility | |
|---|---|
| NPTH Average Weekly Movement | 8.5% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: NPTH has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: NPTH's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 156 | Joe Walewicz | www.neupath.com |
NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists.
NeuPath Health Inc. Fundamentals Summary
| NPTH fundamental statistics | |
|---|---|
| Market cap | CA$11.84m |
| Earnings (TTM) | -CA$852.00k |
| Revenue (TTM) | CA$70.73m |
0.2x
P/S Ratio-13.9x
P/E RatioIs NPTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPTH income statement (TTM) | |
|---|---|
| Revenue | CA$70.73m |
| Cost of Revenue | CA$57.26m |
| Gross Profit | CA$13.46m |
| Other Expenses | CA$14.32m |
| Earnings | -CA$852.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | 19.04% |
| Net Profit Margin | -1.20% |
| Debt/Equity Ratio | 26.6% |
How did NPTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/15 21:38 |
| End of Day Share Price | 2025/01/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuPath Health Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Justin Keywood | Stifel Canada |